期刊文献+

E-cadherin和巢蛋白在鼻咽癌组织中的表达及临床意义 被引量:2

Expression and clinical significance of E-cadherin and Nestin in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的研究E-钙黏蛋白(E-cadherin)、巢蛋白、Ki67和P53在鼻咽癌组织中的表达及其临床意义。方法应用免疫组织化学方法检测E-cadherin、巢蛋白、Ki67和P53在鼻咽癌组织(鼻咽癌组)和鼻咽炎组织(对照组)中的表达情况,并分析E-cadherin和巢蛋白的表达与鼻咽癌临床病理参数的关系。结果在鼻咽癌组织中E-cadherin和巢蛋白阳性表达率分别为11.63%和69.77%,在鼻咽炎组织中的阳性表达率分别为85.72%和9.52%,2组比较差异均有统计学意义(P均<0.05);Ki67和P53在鼻咽癌组织中的阳性表达率分别为93.02%和88.37%,在鼻咽炎组织中的阳性表达率分别为9.52%和4.76%,2组比较差异均有统计学意义(P均<0.05)。E-cadherin在有淋巴结转移组和无淋巴结转移组的阳性表达率分别为3.33%和30.77%,巢蛋白在有淋巴结转移组和无淋巴结转移组的阳性表达率分别为90.00%和23.08%,2组比较差异均有统计学意义(P均<0.05),E-cadherin和巢蛋白的表达与其他病理参数无关(P>0.05);巢蛋白的表达与E-cadherin的表达呈负相关(P<0.01)。结论 E-cadherin和巢蛋白的表达与鼻咽癌淋巴结的转移有一定关系,两者有可能通过共同作用影响鼻咽癌的转移。 Objective To investigate the expression and clinical significance of E-cadherin,Nestin,Ki67 and P53 in nasopharyngeal carcinoma. Methods The expression E-cadherin,Nestin,Ki67 and P53 in nasopharyngeal carcinoma( nasopharyngeal carcinoma group) and nasopharyngitis tissues( control group) were detected by immunohistochemical staining. The relationship between E-cadherin and Nestin and clinicopathological parameters was analyzed. Results The positive rate of E-cadherin and Nestin expression in nasopharyngeal carcinoma group were 11. 63% and 69. 77%,significantly differing from 85. 72% and 9. 52% in the control group( both P〈0. 05). The positive rate of Ki63 and P53 in the nasopharyngeal carcinoma group was93. 02% and 88. 37%,significantly higher compared with 9. 52% and 4. 76% in the control group( both P〈0. 05). The positive rate of E-cadherin expression was 3. 33% and 30. 77% in patients with and without lymph node metastasis,and the Nestin expression were 90. 00% and 23. 08% for the Nestin expression with statistical significance( all P〈0. 05). The expression of E-cadherin and Nestin was not correlated with alternative pathological parameters( both P〉0. 05). The expression of E-cadherin was negatively associated with Nestin expression( P〈0. 01). Conclusion The expression of E-cadherin and Nestin was correlated with the lymph node metastasis of nasopharyngeal carcinoma,which probably together affects the metastasis of nasopharyngeal carcinoma.
出处 《新医学》 2016年第2期122-126,共5页 Journal of New Medicine
关键词 E-钙黏蛋白 巢蛋白 鼻咽癌 免疫组织化学 E-cadherin Nestin Nasopharyngeal carcinoma Immunohistochemistry
  • 相关文献

参考文献21

  • 1Jin X , Jin X, Jung JE, Beck S, Kim H. Cell surface Nestin is a biomarker for glioma stem ceils. Biochem Biophys Res Com- mun, 2013, 433 (4): 496-501.
  • 2Enache S, Arsene D, Iosif C, Stoicea M, Grigore A, Petrescu A, Enache V, Ardeleanu C. Nestin and eaveolin-1 in the diag- nosis of GISTs. Rom J Morphol Embryol, 2012, 53 ( 1 ) : 41- 46.
  • 3Ohnuma A, Yoshida T, Takahashi N, Akema S, Kumagai M, Chiba Y, Kashimoto Y, Kuwahara M, Nakashima N, Harada T. Malignant Leydig cell tumor with spindle-shaped cells in a male CD-I mouse. J Vet Med Sci, 2010, 72 (5) : 661-664.
  • 4Akiyama M, Matsuda Y, Ishiwata T, Naito Z, Kawana S. Inhi- bition of the stem cell marker nestin reduces tumor growth and in- vasion of malignant melanoma. J Invest Dermato, 2013, 133 (5) : 1384-1387.
  • 5Jethwa P, Naqvi M, Hardy RG, Hotchin NA, Roberts S, Spychal R, Tselepis C. Overexpression of Slug is associated with malignant progession of esophageal adenocarcinoma. World J Gas- troenterol, 2008, 14 (7): 1044-1052.
  • 6Rosan6 L, Spinella F, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Exp Biol Med (Maywood), 2006, 231 (6): 1128-1131.
  • 7Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res, 2007, 67 (2) : 501-510.
  • 8于建宪,孙颖,陈桦,纪萍,黄维清,张七一.肝癌组织中CD105与Nestin表达的比较[J].齐鲁医学杂志,2005,20(3):192-194. 被引量:4
  • 9Kolar Z, Ehrmann J Jr, Turashvili G, Bouchal J, Mokry J. A novel myoepithelial/progenitor cell marker in the breast. Vir- chows Arch, 2007, 450 (5) : 607-609.
  • 10Mokr~ J, Nemecek S. Cerebral angiogenesis shows nestin expres- sion in endothelial ceils. Gen Physiol Biophys, 1999, 18 (11) : 25-29.

二级参考文献15

  • 1SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:73
  • 2Lin DY, Lin SM. Nonsurgical treatment of hepatocellular carcinoma [J]. Gastroenterol Hepatology, 1997,12(9) : 5319.
  • 3Takahashi Y, Bucana CD, Cleary KR, et al. P53, vessel count, and vascular endothelial growth factor expression in human colon cancer [J]. Intern J Cancer, 1998, 79: 34.
  • 4Giatromanolaki A, Koukourakis MI, Kakowris S, et al. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer [J]. Clinical Cancer Research, 1998, 4: 3017.
  • 5Lindmark G, Gerdin B, Sundberg G, et al, Prognostic significance of the micro vascular count in colorectal cancer [J]. Clin Oncol, 1996,14:461.
  • 6Vermulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation [J]. Eur J Cancer, 1996,32A:2474.
  • 7Holmgren L. Antiangiogenesis restricted tumor dormancy[J]. Cancer Metastersis Res, 1996,15 : 241.
  • 8Ken-ichi S, Hideyuki K, Mitsuko N, et al. Nestin as a marker for proliferative endothelium in gliomas [J]. Labor Invest,2002,82(30) :345.
  • 9Kay NE, Bone ND, Tschumper RC, et al. B-CLL cells are capable of synthesis and secretion of both pro and anti-angiogenic molecules[J]. Leukemia, 2002,16: 911.
  • 10Keniehi S, Hideyuki K, Mitsuko N, et al. Nestin as a marker for proliferative endothelium in gliomas[J]. Cell, 2002, 82(30):345.

共引文献3

同被引文献5

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部